Repression of M-phase Phosphoprotein 8 Inhibits Melanoma Growth and Metastasis and

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 23

PMID 31966565

Citations 4

Authors

Bo Yuan

Lei Lin

Zhen-Yi Ying

Meng-Xia Ying

Qiong-Yan Zhou

Lei Shi

Affiliations

Soon will be listed here.

Abstract

Metastatic melanoma accounts for the majority of skin cancer deaths due to its aggressiveness and high resistance to current therapies. M-phase phosphoprotein 8 (MPP8) has been shown to bind to methylated H3K9 and promote tumor cell motility and invasion. The current study aimed to investigate the role of MPP8 in melanoma growth and metastasis. Our results showed that MMP8 was up-regulated in the metastatic melanoma specimens. Knockdown of MPP8 inhibited melanoma cell growth both and . Furthermore, down-regulation of MPP8 induced S-phase cell cycle arrest as well as altered expression of cell cycle-related proteins in melanoma cells. In addition, repression of MPP8 inhibited the migration and invasion of melanoma cells both and . Taken together, these data suggest that MPP8 knockdown could inhibit the growth and metastasis of melanoma cells and provide novel therapeutic target for melanoma treatment.

Citing Articles

miR‑576‑3p/M‑phase phosphoprotein 8 axis regulates the malignant progression of hepatocellular carcinoma cells via the PI3K/Akt signaling pathway.

Zhang N, Chi M, Pan W, Zhang C, Wang Y, Gao X Oncol Lett. 2024; 28(1):327.

PMID: 38807669 PMC: 11130756. DOI: 10.3892/ol.2024.14460.

Keep quiet: the HUSH complex in transcriptional silencing and disease.

Muller I, Helin K Nat Struct Mol Biol. 2024; 31(1):11-22.

PMID: 38216658 DOI: 10.1038/s41594-023-01173-7.

Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance.

Peng J, Lin Z, Chen W, Ruan J, Deng F, Yao L Heliyon. 2023; 9(7):e17714.

PMID: 37456058 PMC: 10345356. DOI: 10.1016/j.heliyon.2023.e17714.

MPP8 Promotes Proliferation and Restrains Apoptosis in Osteosarcoma by Regulating p38αMAPK Pathway.

Li T, Li N, Wang L, Li J, Zhang X Technol Cancer Res Treat. 2021; 20:1533033821995272.

PMID: 33596786 PMC: 7897825. DOI: 10.1177/1533033821995272.

References

Bua D, Kuo A, Cheung P, Liu C, Migliori V, Espejo A . Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks. PLoS One. 2009; 4(8):e6789. PMC: 2777412. DOI: 10.1371/journal.pone.0006789. View

Chiang A, Massague J . Molecular basis of metastasis. N Engl J Med. 2008; 359(26):2814-23. PMC: 4189180. DOI: 10.1056/NEJMra0805239. View

McCaffrey L, Macara I . Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol. 2011; 21(12):727-35. DOI: 10.1016/j.tcb.2011.06.005. View

Huang F, Steeg P, Price J, Chiu W, Chou P, Xie K . Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res. 2008; 68(23):9634-42. PMC: 7418219. DOI: 10.1158/0008-5472.CAN-08-1429. View

Gibney G, Kudchadkar R, DeConti R, Thebeau M, Czupryn M, Tetteh L . Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma. Clin Cancer Res. 2014; 21(4):712-20. PMC: 4620684. DOI: 10.1158/1078-0432.CCR-14-2468. View

Livingstone E, Swann S, Lilla C, Schadendorf D, Roesch A . Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma. Exp Dermatol. 2015; 24(9):709-10. DOI: 10.1111/exd.12718. View

Shain A, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A . The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med. 2015; 373(20):1926-36. DOI: 10.1056/NEJMoa1502583. View

Thiery J . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442-54. DOI: 10.1038/nrc822. View

Parmiani G . Melanoma Cancer Stem Cells: Markers and Functions. Cancers (Basel). 2016; 8(3). PMC: 4810118. DOI: 10.3390/cancers8030034. View

10.

Branco-Price C, Evans C, Johnson R . Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon. Oncotarget. 2013; 4(12):2567-76. PMC: 3926849. DOI: 10.18632/oncotarget.1461. View

11.

Kokura K, Sun L, Bedford M, Fang J . Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion. EMBO J. 2010; 29(21):3673-87. PMC: 2982762. DOI: 10.1038/emboj.2010.239. View

12.

Orgaz J, Sanz-Moreno V . Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res. 2012; 26(1):39-57. DOI: 10.1111/pcmr.12041. View

13.

Bishop J . Molecular themes in oncogenesis. Cell. 1991; 64(2):235-48. DOI: 10.1016/0092-8674(91)90636-d. View

14.

Sun L, Kokura K, Izumi V, Koomen J, Seto E, Chen J . MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition. EMBO Rep. 2015; 16(6):689-99. PMC: 4467853. DOI: 10.15252/embr.201439792. View

15.

Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View

16.

Pirollet F, MONROE R, Gerace L, Westendorf J . Identification of novel M phase phosphoproteins by expression cloning. Mol Biol Cell. 1996; 7(9):1455-69. PMC: 275994. DOI: 10.1091/mbc.7.9.1455. View

17.

Chang Y, Horton J, Bedford M, Zhang X, Cheng X . Structural insights for MPP8 chromodomain interaction with histone H3 lysine 9: potential effect of phosphorylation on methyl-lysine binding. J Mol Biol. 2011; 408(5):807-14. PMC: 3081990. DOI: 10.1016/j.jmb.2011.03.018. View

18.

Li J, Li Z, Ruan J, Xu C, Tong Y, Pan P . Structural basis for specific binding of human MPP8 chromodomain to histone H3 methylated at lysine 9. PLoS One. 2011; 6(10):e25104. PMC: 3192050. DOI: 10.1371/journal.pone.0025104. View

19.

Murata K, Sato S, Haruta M, Goshima T, Chiba Y, Takahashi S . Physical interaction between MPP8 and PRC1 complex and its implication for regulation of spermatogenesis. Biochem Biophys Res Commun. 2015; 458(3):470-475. DOI: 10.1016/j.bbrc.2015.01.122. View

20.

Hutchinson L . Skin cancer: Novel resistance mechanism revealed. Nat Rev Clin Oncol. 2011; 9(1):5. DOI: 10.1038/nrclinonc.2011.195. View